Literature DB >> 28029920

More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.

James C M Brust1,2, N Sarita Shah3, Neel R Gandhi4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28029920      PMCID： PMC5526325          DOI： 10.1056/NEJMc1613123

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

Authors:  K F Laserson; L E Thorpe; V Leimane; K Weyer; C D Mitnick; V Riekstina; E Zarovska; M L Rich; H S F Fraser; E Alarcón; J P Cegielski; M Grzemska; R Gupta; M Espinal
Journal:  Int J Tuberc Lung Dis       Date:  2005-06       Impact factor: 2.373

2.  Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Authors:  Gunar Günther; Christoph Lange; Sofia Alexandru; Neus Altet; Korkut Avsar; Didi Bang; Raisa Barbuta; Graham Bothamley; Ana Ciobanu; Valeriu Crudu; Manfred Danilovits; Martin Dedicoat; Raquel Duarte; Gina Gualano; Heinke Kunst; Wiel de Lange; Vaira Leimane; Cecile Magis-Escurra; Anne-Marie McLaughlin; Inge Muylle; Veronika Polcová; Christina Popa; Rudolf Rumetshofer; Alena Skrahina; Varvara Solodovnikova; Victor Spinu; Simon Tiberi; Piret Viiklepp; Frank van Leth
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

3.  Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.

Authors:  Carole D Mitnick; Richard A White; Chunling Lu; Carly A Rodriguez; Jaime Bayona; Mercedes C Becerra; Marcos Burgos; Rosella Centis; Theodore Cohen; Helen Cox; Lia D'Ambrosio; Manfred Danilovitz; Dennis Falzon; Irina Y Gelmanova; Maria T Gler; Jennifer A Grinsdale; Timothy H Holtz; Salmaan Keshavjee; Vaira Leimane; Dick Menzies; Giovanni Battista Migliori; Meredith B Milstein; Sergey P Mishustin; Marcello Pagano; Maria I Quelapio; Karen Shean; Sonya S Shin; Arielle W Tolman; Martha L van der Walt; Armand Van Deun; Piret Viiklepp
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

Review 4.  A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment.

Authors:  Chunling Lu; Qing Liu; Aartik Sarma; Christopher Fitzpatrick; Dennis Falzon; Carole D Mitnick
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.